In just three years, immuno-oncology company
Read the full interview with Martin Welschof at biostock.se:
https://www.biostock.se/en/2021/09/bioinvents-ceo-on-the-benefits-of-a-diversified-portfolio/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
https://news.cision.com/bioinvent-international-ab/r/biostock-bioinvent-s-ceo-on-the-benefits-of-a-diversified-portfolio,c3422698
(c) 2021 Cision. All rights reserved., source